Dr. Lianghong Sheng joined Greenwoods in 2011 with over 12 years of operational and M&A experience in the pharmaceutical industry. Dr. Sheng was formerly the General Manager of Huali Jingang Pharmaceutical, Assistant GM of Investments at Simcere Pharmaceutical, and R&D Director of Honghui Medical.
Led investments in Gan & Lee Pharmaceuticals (SHSE: 603087), Konruns Pharmaceutical, Phoenix Healthcare (1515.HK), and more.
MS Degree in Pharmacology from Hunan University of Chinese Medicine, PhD Degree from China Pharmaceutical University, MBA Degree from Nanjing University.
